ReportWire

Tag: Humana

  • Humana’s Medicare Advantage star ratings slip for 2026

    This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter.

    • Humana will have 20% of its Medicare Advantage members in plans rated 4 stars or above in 2026, down slightly from 2025 but in line with internal expectations, the insurer disclosed Thursday.

    • Humana — the second largest MA carrier in the country — did see an improvement in members in plans rated 4.5 stars or above. Next year, 14% of Humana’s MA members will be in those highly rated plans, up from 3% in 2025.

    • Humana’s average star rating of 3.61 is roughly stable year over year. The insurer, which has been working to improve its ratings, said it was unsatisfied with the results. Still, Humana’s stock rose about 3% in Thursday’s trade following its disclosure.

    It’s busy season for insurance market watchers, with the CMS releasing more information on the Medicare Advantage landscape for the coming year — including by mistake.

    On Wednesday, regulators published more detailed information on MA plan offerings for 2026 and inadvertantly released some star ratings data, leading Humana to file its own disclosure to investors, the insurer said.

    Though Humana’s average star rating remained essentially unchanged, the results are overall likely disappointing for the insurer. That’s because the percentage of MA members in plans rated 4 stars or higher dropped from 25% this year.

    To put that further into context, Humana had 94% of members in plans rated at least 4 stars in 2024.

    Reaching that threshold is key for insurers in the privatized Medicare program. Plans that receive an overall rating of 4 or higher receive higher bonus payments. Higher scores also result in larger rebates if plans submit bids below the CMS’ benchmark for the coming year.

    Humana expects to lose billions of dollars in revenue as a result of the star ratings drop from 2024 to 2025, so a further dip for 2026 won’t help.

    “While the Company is not satisfied with its 2026 Star Ratings, it is pleased with the tactical operational improvements made during the final months of the 2026 measurement period, creating a solid foundation for the Company’s expected return to Top Quartile results for the 2027 Star Ratings,” Humana said in its securities filing

    Along with suing the government in a bid to improve its scores, Humana has hustled to improve its ratings by closing gaps in care, increasing member outreach and investing in technology, according to executive comments.

    Source link

  • Cigna resumes merger discussions with Humana, Bloomberg News reports

    Cigna resumes merger discussions with Humana, Bloomberg News reports

    (Reuters) – U.S. health insurer Cigna Group has revived efforts to merge with smaller rival Humana after abandoning the pursuit late last year, Bloomberg News reported on Friday, citing people familiar with the matter.

    The companies have held informal, early discussions recently about a potential deal, the report said.

    Shares of Humana were up about 5% in after-hours trading on Friday, while those of Cigna were down about 4%.

    Last year, Reuters reported that Cigna ended its attempt to negotiate an acquisition of Humana after the pair failed to agree on a price and announced a $10 billion worth of shares buyback.

    By the time the deal talks ended, sources had told Reuters that there was still a possibility of a tie-up in the future.

    Cigna struck a $3.3 billion deal with insurer Health Care Service Corp earlier this year to sell its Medicare business that manages government-backed health insurance for people aged 65 and older.

    Should a merger between Cigna and Humana occur, it could create a company with a value nearing $130 billion, based on their market values.

    Humana has lost nearly 40% of its value this year as it has been struggling with declining enrollments in its top-rated Medicare insurance plans and elevated costs due to higher demand for medical care.

    Cigna and Humana declined to comment.

    (This story has been refiled to fix a typo in paragraph 7)

    (Reporting by Mariam Sunny in Bengaluru; Editing by Alan Barona)

    Source link

  • Medicare Advantage shopping season arrives with a dose of confusion and some political implications

    Medicare Advantage shopping season arrives with a dose of confusion and some political implications

    Thinner benefits and coverage changes await many older Americans shopping for health insurance this fall. That’s if their plan is even still available in 2025.

    More than a million people will probably have to find new coverage as major insurers cut costs and pull back from markets for Medicare Advantage plans, the privately run version of the federal government’s coverage program mostly for people ages 65 and older.

    Industry experts also predict some price increases for Medicare prescription drug plans as required coverage improvements kick in.

    Voters will learn about the insurance changes just weeks before they pick the next president and as Democrat Kamala Harris campaigns on promises to lower health care costs. Early voting has already started in some states.

    “This could be bad news for Vice President Harris. If that premium is going up, that’s a very obvious sign that you’re paying more,” said Massey Whorley, an analyst for health care consulting company Avalere. “That has significant implications for how they’re viewing the performance of the current administration.”

    Insurance agents say the distraction of the election adds another complication to an already challenging annual enrollment window that starts next month.

    Insurers are pulling back from Medicare Advantage

    Medicare Advantage plans will cover more than 35 million people next year, or around half of all people enrolled in Medicare, according to the federal government. Insurance agents say they expect more people than usual will have to find new coverage for 2025 because their insurer has either ended a plan or left their market.

    The health insurer Humana expects more than half a million customers — about 10% of its total — to be affected as it pulls Medicare Advantage plans from places around the country. Many customers will be able to transfer to other Humana plans, but company leaders still anticipate losing a few hundred thousand customers.

    CVS Health’s Aetna projects a similar loss, and other big insurers have said they are leaving several states.

    Insurers say rising costs and care use, along with reimbursement cuts from the government, are forcing them to pull back.

    Some people can expect a tough search

    When insurers leave Medicare Advantage markets, they tend to stop selling plans that have lower quality ratings and those with a higher proportion of Black buyers, said Dr. Amal Trivedi, a Brown University public health researcher.

    He noted that market exits can be particularly hard on people with several doctors and on patients with cognitive trouble like dementia.

    Most markets will still have dozens of plan choices. But finding a new option involves understanding out-of-pocket costs for each choice, plus figuring out how physicians and regular prescriptions are covered.

    “People don’t like change when it comes to health insurance because you don’t know what’s on the other side of the fence,” said Tricia Neuman, a Medicare expert at KFF, a nonprofit that researches health care.

    Plans that don’t leave markets may raise deductibles and trim perks like cards used to pay for utilities or food.

    Those proved popular in recent years as inflation rose, said Danielle Roberts, co-founder of the Fort Worth, Texas, insurance agency Boomer Benefits.

    “It’s really difficult for a person on a fixed income to choose a health plan for the right reasons … when $900 on a flex card in free groceries sounds pretty good,” she said.

    Don’t “sleep” on picking a Medicare plan

    Prices also could rise for some so-called standalone Part D prescription drug plans, which people pair with traditional Medicare coverage. KFF says that population includes more than 13 million people.

    The Centers for Medicare and Medicaid Services said Friday that premiums for these plans will decrease about 4% on average to $40 next year.

    But brokers and agents say premiums can vary widely, and they still expect some increases. They also expect fewer plan choices and changes to formularies, or lists of covered drugs. Roberts said she has already seen premium hikes of $30 or more from some plans for next year.

    Any price shift will hit a customer base known to switch plans for premium changes as small as $1, said Fran Soistman, CEO of the online insurance marketplace eHealth.

    The changes come as a congressional-approved coverage overhaul takes hold. Most notably, out-of-pocket drug costs will be capped at $2,000 for those on Medicare, an effort championed by Democrats and President Joe Biden in 2022.

    In the long run, these changes will lead to a “much richer benefit,” Whorley said.

    KFF’s Neuman noted that the cap on drug costs will be especially helpful to cancer patients and others with expensive prescriptions. She estimates about 1.5 million people will benefit.

    To ward off big premium spikes because of the changes, the Biden administration will pull billions of dollars from the Medicare trust fund to pay insurers to keep premium prices down, a move some Republicans have criticized. Insurers will not be allowed to raise premium prices beyond $35 next year.

    People will be able to sign up for 2025 coverage between Oct. 15 and Dec. 7. Experts say all the potential changes make it important for shoppers to study closely any new choices or coverage they expect to renew.

    “This is not a year to sleep on it, just re-enroll in the status quo,” said Whorley, the health care analyst.

    ___

    The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

    Source link

  • WSJ News Exclusive | Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback

    WSJ News Exclusive | Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback

    Updated Dec. 10, 2023 4:47 pm ET

    Cigna Group abandoned its pursuit of a tie-up with Humana after shareholders balked at a deal that would have created a roughly $140 billion giant in the health-insurance industry.

    The companies couldn’t come to agreement on price and other financial terms, according to people familiar with the matter. In the near term, Cigna is turning its focus toward smaller, so-called bolt-on, acquisitions.

    Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

    Source link